Canagliflozin CV Benefits Appear to Be Dose-Dependent ...Middle East

Medscape - News
Canagliflozin CV Benefits Appear to Be Dose-Dependent
A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug. Medscape Medical News

Hence then, the article about canagliflozin cv benefits appear to be dose dependent was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Canagliflozin CV Benefits Appear to Be Dose-Dependent )

Apple Storegoogle play

Last updated :

Also on site :